Teleman Dan Benjamin

Track

Insider profile

Performance

Overall performance
3.2
Performance over holding periods
3.2
30 days 90 days 120 days
Average return 8% 8.2% 15.1%
Success rate 37% 68% 82%
Transactions
4 100% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Teleman Dan Benjamin's trades of Nasus Pharma Ltd's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Purchase
Price
261.11
Quantity 15,170 -3.7%
Value US$4,119,075
Transaction date
Purchase
Price
177.62
Quantity 61,381 +42.8%
Value US$3,174,867
Transaction date
Purchase
Price
252.02
Quantity 63,507 -18.0%
Value US$3,175,342
Transaction date
Purchase
Price
2.04
Quantity 15,000 +240.2%
Value US$30,600
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-06-22 2026-06-17
B Purchase
15,170 -3.7%
261.11
US$4,119,075 		15,170 -3.7% 261.11 US$4,119,075
2026-06-22 2026-06-17
B Purchase
61,381 +42.8%
177.62
US$3,174,867 		61,381 +42.8% 177.62 US$3,174,867
2026-04-22 2026-04-22
B Purchase
63,507 -18.0%
252.02
US$3,175,342 		63,507 -18.0% 252.02 US$3,175,342
2026-04-01 2026-03-31
B Purchase
15,000 +240.2%
2.04
US$30,600 		15,000 +240.2% 2.04 US$30,600